Champlain Investment Partners LLC purchased a new stake in shares of Stevanato Group S.p.A. (NYSE:STVN - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 770,849 shares of the company's stock, valued at approximately $15,741,000. Champlain Investment Partners LLC owned approximately 0.25% of Stevanato Group as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in the company. Conestoga Capital Advisors LLC raised its stake in Stevanato Group by 1.3% during the first quarter. Conestoga Capital Advisors LLC now owns 8,189,926 shares of the company's stock valued at $167,238,000 after buying an additional 106,930 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its stake in shares of Stevanato Group by 13.3% in the first quarter. T. Rowe Price Investment Management Inc. now owns 3,744,714 shares of the company's stock worth $76,468,000 after purchasing an additional 439,722 shares during the last quarter. TimesSquare Capital Management LLC raised its stake in shares of Stevanato Group by 2.1% in the first quarter. TimesSquare Capital Management LLC now owns 3,358,966 shares of the company's stock worth $68,590,000 after purchasing an additional 70,437 shares during the last quarter. Bamco Inc. NY raised its stake in shares of Stevanato Group by 7.9% in the fourth quarter. Bamco Inc. NY now owns 1,818,181 shares of the company's stock worth $39,618,000 after purchasing an additional 133,000 shares during the last quarter. Finally, Jennison Associates LLC raised its stake in shares of Stevanato Group by 27.9% in the first quarter. Jennison Associates LLC now owns 1,188,057 shares of the company's stock worth $24,260,000 after purchasing an additional 259,231 shares during the last quarter.
Stevanato Group Stock Performance
Stevanato Group stock traded down €0.32 during mid-day trading on Friday, reaching €23.14. 254,200 shares of the stock traded hands, compared to its average volume of 356,268. The business's 50-day moving average is €24.22 and its 200-day moving average is €22.51. Stevanato Group S.p.A. has a 12-month low of €17.12 and a 12-month high of €28.00. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.79 and a quick ratio of 1.22. The stock has a market capitalization of $7.01 billion, a PE ratio of 42.85, a price-to-earnings-growth ratio of 2.17 and a beta of 0.55.
Analyst Ratings Changes
Separately, William Blair restated an "outperform" rating on shares of Stevanato Group in a research note on Monday, June 30th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Stevanato Group has an average rating of "Moderate Buy".
Read Our Latest Stock Analysis on Stevanato Group
Stevanato Group Profile
(
Free Report)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Recommended Stories

Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.